Diabetic Macular Oedema (DME) Study

This is a Phase 4 progressive study of a treatment currently available to patients with macular oedema due to diabetic macular oedema (DME).

KEY INCLUSION CRITERIA

Inclusion Criteria:

  • Participants aged 18 years and over.
  • Had cataract surgery or scheduled for a cataract operation.
  • Diagnosed with macular oedema in one or both eyes due to diabetic macular oedema DME.

Exclusion Criteria:

  • Participation in another clinical trial or investigations involving treatment with an investigational drug or chemical within the past 6 months.
  • Participants using other concurrent intravitreal injections. 
  • Women who are pregnant, nursing or childbearing potential without adequate contraception. 
     

Minimum Age:

18 Years

Gender:

Both

EXPRESS YOUR INTEREST IN DME STUDY


To enable our ophthalmologist to confirm diagnosis, a referral from your optometrist, GP or ophthalmologist is required prior to registering your interest to participate in this study.

Back to Clinical Trials